Literature DB >> 6783704

Mitogenicity and pathogenicity of Mycoplasma pulmonis in rats. I. Atypical interstitial pneumonia induced by mitogenic myeoplasmal membranes.

Y Naot, S Davidson, E S Lindenbaum.   

Abstract

Mitogenic preparations of nonviable lysed cells and purified membranes of Mycoplasma pulmonis induced interstitial pneumonia and tracheitis after intranasal administration to pathogen-free rats. The pneumonia, characterized by peribronchial, perivascular, and alveolar wall infiltration by lymphocytes, was indistinguishable from that produced by viable M. pulmonis. Both pathologic and mitogenic effects were significanlty reduced by prior treatment of membranes with heat or proteolytic enzyme. Intranasal administration of the thymus-derived-cell mitogen, concanavalin A, produced interstitial pneumonia but not tracheitis. These results indicate a correlation of mitogenicity and pathogenicity and suggest that activation of thymus-derived lymphocytes is the major cause of the pneumonia resulting from infections with M. pulmonis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783704     DOI: 10.1093/infdis/143.1.55

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Mycoplasma pulmonis possesses a novel chemoattractant for B lymphocytes.

Authors:  S E Ross; J W Simecka; G P Gambill; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination.

Authors:  M Merkenschlager; D Kardamakis; F C Rawle; N Spurr; P C Beverley
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

3.  Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences.

Authors:  J K Davis; J W Simecka; J S Williamson; S E Ross; M M Juliana; R B Thorp; G H Cassell
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

4.  Stimulation of DNA synthesis on animal cell microcultures by a heat-stable cytoplasmic factor of Entamoeba histolytica.

Authors:  A Valadez-Salazar; R López-Revilla
Journal:  Z Parasitenkd       Date:  1986

5.  Monoclonal antibodies that inhibit mitogenic activity of Mycoplasma pulmonis.

Authors:  Z Lapidot; R Siman-Tov; Y Naot
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Murine respiratory mycoplasmosis in F344 and LEW rats: evolution of lesions and lung lymphoid cell populations.

Authors:  J K Davis; R B Thorp; P A Maddox; M B Brown; G H Cassell
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis.

Authors:  J W Simecka; P Patel; J K Davis; S E Ross; P Otwell; G H Cassell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Polyclonal activation of rat splenic lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in vitro response.

Authors:  J S Williamson; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

9.  Delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice is enhanced by dextran sulfate.

Authors:  M Kishima; C Kuniyasu; M Nakagawa
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat.

Authors:  D M McDonald; T R Schoeb; J R Lindsey
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.